HeraMED Limited launched its medical grade foetal heart rate monitor, HeraBEAT. The specially designed website for the device is now live (www.hera-beat.com.au) and the company expects device sales to commence in the region in the coming months. HeraMED has also implemented a strategic marketing campaign associated with the website will begin on 26 June 2019. The marketing campaign will be led by HeraMED partner, Meerkats. Meerkats is a top-tier Australian creative agency that has been assisting organizations to grow through creativity and innovation for over 15 years. The group has a national footprint and services brands including St John Ambulance and iiNet. The marketing campaign will be led by HeraMED partner, Meerkats (ASX announcement: 16 April 2019). Meerkats is a top-tier Australian creative agency that has been assisting organizations to grow through creativity and innovation for over 15 years. The group has a national footprint and services brands including St John Ambulance and iiNet. The company advises that all copy and design are finalised and will be deployed through digital and social media channels in the coming days. Both Meerkats and HeraMED have identified initial target audiences, which will provide the base of the campaign. HeraMED anticipates that this marketing campaign will underpin sales growth and drive device uptake broadly throughout the region. The campaign will also assist to build awareness around HeraMED as it engages with Australian medical organizations to progress its top down strategy. As part of the launch, Meerkats will receive a pre-negotiated commission from the Company's Australian distributor Dale Group International for each device sold. This provides validation HeraBEAT's potential with Australian consumers and HeraMED is confident that this remuneration structure will incentivise Meerkats to drive initial sales.